Temporal trends of the lung cancer mortality attributable to smoking from 1990 to 2017: A global, regional and national analysis

Yang, Xiaorong; Man, Jinyu; Chen, Hui; Zhang, Tongchao; Yin, Xiaolin; He, Qian; Lü, Ming

doi:10.1016/j.lungcan.2020.12.007

Cited by 50 publications

(47 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CIs were calculated from 1000 draw-level estimates for each parameter and 95% CIs were de ned by the 25th and 975th values of the ordered 1000 estimates; a 95% CI excluding 0 was considered statistically signi cant. To investigate the dynamic changes of IE burden, we further calculated the estimated annual percentage change (EAPC) to delineate the temporal trend in different ASRs of IE burden [20]. We performed a regression model tting the natural logarithm of the ASR with the calendar year, namely, ln (ASR) = α + β* calendar year + ε, to estimate the EAPC with its 95% con dence interval (CI) based on the formula of 100 × (exp (β) − 1).…”

Section: Discussionmentioning

confidence: 99%

The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019

Chen¹,

Zhan²,

Zhang³

et al. 2021

Preprint

View full text Add to dashboard Cite

Introduction: Infective endocarditis (IE) causes in-mounting incidence and mortality, as well as serious socioeconomic burden in different regions and countries. To compare and interpret the IE burden and temporal trends in the globe and different regions, we conducted this study to report the incidence, death, and disability-adjusted life years (DALYs) from 1990 to 2019. Methods: Data of incidences, deaths and DALYs were extracted and analyzed from the Global Burden of Disease Study 2019. Estimated annual percentage changes (EAPC) were adopted to quantify the change trends of age-standardized rates (ASRs). Besides, potential contributors of serious IE burden were also evaluated including age, gender, social-demographic index (SDI), and ASIR in 1990.Results: In the globe, the number of IE cases increased by 128% from 478,000 in 1990 to 1,090,530 in 2019, and the deaths increased sharply from 28,750 in 1990 to 66,320 in 2019, and both presented the upward temporal trend annually. Whereas the EAPC of age-standardized DALYs demonstrated a negative temporal trend despite of increasing DALYs from 1,118,120 in 1990 to 1,723,590 in 2019. Moreover, graver IE burden was prone to males and aged patients. Meanwhile, different SDI regions had different disease burden, correlation analyses indicated that SDI presented a positive association with ASIR (R=0.58, P<0.0001), no association with ASDR (R=-0.06, P=0.10), and negative association with age-standardized DALYs rate (R=-0.40, P<0.0001). Finally, we discovered the positive associations of EAPC of ASRs with SDI in 2019, while little associations with ASIR in 1990.Conclusion: Generally, the overall burden of infective endocarditis is ever-increasing, and the incidence, mortality and disability-adjusted life years present a huge heterogeneity in gender, age and different regions. The results may be useful for policy makers and medical staffs in response to endocarditis and to formulate cost-effective interventional measures.

show abstract

Section: Discussionmentioning

confidence: 99%

The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019

Chen¹,

Zhan²,

Zhang³

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…The 95% uncertainty intervals (UIs) for every metric in the GBD study were calculated based on the 25th and 975th ordered values of 1000 random draws of the posterior distribution. We further calculated the estimated annual percentage change (EAPC) to describe the temporal trend in various age-standardised rates (ASRs) of anxiety disorders burden (Yang et al ., 2020 ). We performed a regression model fitting the natural logarithm of the ASR with the calendar year, namely, ln (ASR) = α + β * calendar year + ɛ, to estimate the EAPC with its 95% confidence interval (CI) based on the formula of 100 × (exp ( β ) − 1).…”

Section: Methodsmentioning

confidence: 99%

Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019

Yang

Fang

Chen

et al. 2021

Epidemiol Psychiatr Sci

Self Cite

164

View full text Add to dashboard Cite

Aims Anxiety disorders are widespread across the world. A systematic understanding of the disease burden, temporal trend and risk factors of anxiety disorders provides the essential foundation for targeted public policies on mental health at the national, regional, and global levels. Methods The estimation of anxiety disorders in the Global Burden of Disease Study 2019 using systematic review was conducted to describe incidence, prevalence and disability-adjusted life years (DALYs) in 204 countries and regions from 1990 to 2019. We calculated the estimated annual percentage change (EAPC) to quantify the temporal trends in anxiety disorders burden by sex, region and age over the past 30 years and analysed the impact of epidemiological and demographic changes on anxiety disorders. Results Globally, 45.82 [95% uncertainty interval (UI): 37.14, 55.62] million incident cases of anxiety disorders, 301.39 million (95% UI: 252.63, 356.00) prevalent cases and 28.68 (95% UI: 19.86, 39.32) million DALYs were estimated in 2019. Although the overall age-standardised burden rate of anxiety disorders remained stable over the past three decades, the latest absolute number of anxiety disorders increased by 50% from 1990. We observed huge disparities in both age-standardised burden rate and changing trend of anxiety disorders in sex, country and age. In 2019, 7.07% of the global DALYs due to anxiety disorders were attributable to bullying victimisation, mainly among the population aged 5–39 years, and the proportion increased in almost all countries and territories compared with 1990. Conclusion Anxiety disorder is still the most common mental illness in the world and has a striking impact on the global burden of disease. Controlling potential risk factors, such as bullying, establishing effective mental health knowledge dissemination and diversifying intervention strategies adapted to specific characteristics will reduce the burden of anxiety disorders.

show abstract

“…The screening process of the patients is shown in Figure 1. The inclusion criteria included: (1) primary site: lung and bronchus; (2) extension, grade, laterality, cause-speci c death classi cation, survival months and vital status, surgery, radiotherapy, and chemotherapy, among others. We then converted the TNM stages based on the AJCC 7th edition to those of the 8th edition for each patient by using tumor size, tumor CS extension, and 7th edition N/M stages.…”

Section: Data Sourcementioning

confidence: 99%

“…Lung cancer is the most common malignancy worldwide causing the greatest number of tumor-related deaths. Pathologically, lung cancer is divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), of which NSCLC accounts for 85% of cases [1,2]. Similar to other malignancies, the proportion of patients with NSCLC who are older (aged 65 years or older) has increased in recent years due to the increasing aging of the global population [3,4].…”

Section: Introductionmentioning

confidence: 99%

Do Older Patients with Stage IB Non-Small-Cell Lung Cancer Obtain Survival Benefit from Surgery? A Propensity Score Matching Study Based on the SEER Database

Xian

Liu

Wang

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Although surgery is the preferred treatment method for early-stage non-small-cell lung cancer (NSCLC), more than a third of older patients with stage IB NSCLC didn’t receive surgical treatment. Methods: Data of patients with NSCLC was downloaded from the SEER (Surveillance, Epidemiology, and End Results) database, converted from the 7th edition staging to those of the 8th edition staging, and then screened out older patients (aged ≥65 years at diagnosis) with stage IB NSCLC. The propensity score matching (PSM) method was were balanced the distribution proportions of clinical characteristics between the surgery and no surgery groups.Results: After 1:1 propensity score matching, the distribution proportions of clinical characteristics were balanced between the surgery and no surgery groups (P > 0.05, all). The overall survival and disease-specific survival of patients in the surgery group were significantly better than those in the no-surgery group (P < 0.001, both). Furthermore, subgroup analysis showed that receiving surgery was a protective factor for overall survival and disease-specific survival of patients in all clinical character-related subgroups. Ultimately, univariate and multivariate Cox regression analyses showed that gender, tumor size, tumor grade, and tumor classification were independent prognostic factors for overall survival and disease-specific survival in patients undergoing surgery. Conclusions: Older patients with Stage IB NSCLC should opt for surgery without hesitation. This study is expected to provide strong evidence-based medical evidence for the surgical treatment of these patients.

show abstract

Temporal trends of the lung cancer mortality attributable to smoking from 1990 to 2017: A global, regional and national analysis

Cited by 50 publications

References 26 publications

The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019

The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019

Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019

Do Older Patients with Stage IB Non-Small-Cell Lung Cancer Obtain Survival Benefit from Surgery? A Propensity Score Matching Study Based on the SEER Database

Contact Info

Product

Resources

About